Johns Hopkins ABX Guide
Natamycin
INDICATIONS
FDA
FDA
- Treatment of fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms, including Fusarium solani.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: February 17, 2021
Citation
Dzintars, Kathryn . "Natamycin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2021. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540734/all/Natamycin.
Dzintars K. Natamycin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2021. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540734/all/Natamycin. Accessed October 10, 2024.
Dzintars, K. (2021). Natamycin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540734/all/Natamycin
Dzintars K. Natamycin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2021. [cited 2024 October 10]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540734/all/Natamycin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Natamycin
ID - 540734
A1 - Dzintars,Kathryn ,Pharm.D., BCPS
Y1 - 2021/02/17/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540734/all/Natamycin
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
